Analysis for Quest Diagnostics
Analysis summary
Quest Diagnostics (DGX) currently has a total score of 66 points, placing it in the strong range. The score is made up of Performance (61), Stability (74) and Trend (65). All three sub-scores are currently above average.
Performance scores 61 points (strong). Key strength: 1Y return at 21.3 %. Even the weakest return is still strong in absolute terms: 3Y return at 40.1 %.
Stability scores 74 points (strong). Best-ranked metric: max drawdown (1Y) at -9.8 %. Even the weakest metric remains solid in absolute terms: Sharpe ratio (90d) at 0.88. Higher Stability points are better and typically reflect calmer swings and smaller drawdowns—but prices can still fall.
Trend scores 65 points (strong). Key strength: Price is about 11.4 % above SMA50. Main drag: trend strength at 0.27. That often means the move is strong, but not perfectly steady.
Overall, the score is shaped most by Stability; Performance trails and dampens the total. On a metric level, max drawdown (1Y) stands out, while trend strength is the main weak spot.
(Historical evaluation, not investment advice.)
Metrics
Stability
FAQ
- What investor type does Quest Diagnostics fit best in FoxScore?
- Quest Diagnostics fits a more defensive investor type in FoxScore: stability is the strongest part of the profile. That points to comparatively smaller drawdowns and calmer swings versus the universe — but prices can still fall.
- How meaningful is the available history for Quest Diagnostics?
- Quest Diagnostics currently has about 15 years of price history available. That covers multiple market cycles including crisis phases, making long-term interpretation of returns, drawdowns and trend shifts more reliable.
- What is FoxScore good for — and what is it not for?
- FoxScore is an analysis and comparison tool: it helps you sort assets quickly, compare profiles and spot strengths/weaknesses. It’s not a substitute for your own research or fundamental analysis, and it’s not a buy/sell recommendation.